SE437931B - Lekemedelspreparat med antitumorverkan innehallande fosfat av polyhexametylenguanidin med angiven formel - Google Patents

Lekemedelspreparat med antitumorverkan innehallande fosfat av polyhexametylenguanidin med angiven formel

Info

Publication number
SE437931B
SE437931B SE8400453A SE8400453A SE437931B SE 437931 B SE437931 B SE 437931B SE 8400453 A SE8400453 A SE 8400453A SE 8400453 A SE8400453 A SE 8400453A SE 437931 B SE437931 B SE 437931B
Authority
SE
Sweden
Prior art keywords
tumor
preparation
polyhexamethylenguanidine
formula
pharmaceutical composition
Prior art date
Application number
SE8400453A
Other languages
English (en)
Swedish (sv)
Other versions
SE8400453D0 (sv
SE8400453L (sv
Inventor
I Z Lulle
M J Lidak
R A Paegle
A A Zidermane
I M Kravchenko
A P Gilev
T I Kagan
P A Gembitsky
B Z Simkhovich
Original Assignee
Inst Organicheskogo Sinteza Ak
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Organicheskogo Sinteza Ak filed Critical Inst Organicheskogo Sinteza Ak
Publication of SE8400453D0 publication Critical patent/SE8400453D0/xx
Publication of SE437931B publication Critical patent/SE437931B/sv
Publication of SE8400453L publication Critical patent/SE8400453L/
Priority to SU874203066A priority Critical patent/SU1607679A3/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SE8400453A 1982-06-21 1984-01-30 Lekemedelspreparat med antitumorverkan SE8400453L (sv)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU874203066A SU1607679A3 (ru) 1984-01-30 1987-08-11 Способ борьбы с фитопатогенными грибами

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SU1982/000020 WO1984000105A1 (fr) 1982-06-21 1982-06-21 Preparation medicinale ayant un effet antitumoral

Publications (3)

Publication Number Publication Date
SE8400453D0 SE8400453D0 (sv) 1984-01-30
SE437931B true SE437931B (sv) 1985-03-25
SE8400453L SE8400453L (sv) 1985-03-25

Family

ID=21616776

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8400453A SE8400453L (sv) 1982-06-21 1984-01-30 Lekemedelspreparat med antitumorverkan

Country Status (9)

Country Link
JP (1) JPS59501110A (fr)
CA (1) CA1194802A (fr)
CH (1) CH660964A5 (fr)
DE (1) DE3249514T1 (fr)
FR (1) FR2535609A1 (fr)
GB (1) GB2134783B (fr)
NL (1) NL8220420A (fr)
SE (1) SE8400453L (fr)
WO (1) WO1984000105A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344846A (en) * 1992-12-30 1994-09-06 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for inhibiting deoxyhypusine synthase and the growth of cells
DE19628641C2 (de) * 1996-07-16 1998-12-17 Fresenius Ag Verwendung von PHMB zur Behandlung von Tumorerkrankungen
KR100557559B1 (ko) * 1999-12-20 2006-03-03 에스케이 주식회사 폴리헥사메틸렌구아니딘 인산염 분말, 이의 제조방법 및이를 함유한 항균수지
KR100725004B1 (ko) * 1999-12-24 2007-06-04 에스케이 주식회사 살균소독제 조성물 및 이의 사용방법
AT505312A1 (de) 2007-05-15 2008-12-15 Recticel Schlafkomfort Gmbh Sc Polyurethan-werkstoff mit einer bioziden ausrüstung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3824288A (en) * 1961-06-09 1974-07-16 Hoffmann La Roche Substituted hydrazine derivatives and process for the manufacture thereof
BR6457241D0 (pt) * 1963-12-23 1973-06-26 Rohm & Haas Processo para a preparacao de t-octil-guanidinas
GB1492678A (en) * 1975-08-11 1977-11-23 Ici Ltd Guanidine derivatives
JPS5341426A (en) * 1976-09-27 1978-04-14 Asahi Chem Ind Co Ltd Fungicidal and bactericidal agents

Also Published As

Publication number Publication date
SE8400453D0 (sv) 1984-01-30
FR2535609A1 (fr) 1984-05-11
GB2134783A (en) 1984-08-22
JPS59501110A (ja) 1984-06-28
FR2535609B1 (fr) 1985-03-15
WO1984000105A1 (fr) 1984-01-19
NL8220420A (nl) 1984-05-01
DE3249514T1 (de) 1984-05-17
CH660964A5 (de) 1987-06-30
CA1194802A (fr) 1985-10-08
GB2134783B (en) 1985-10-30
SE8400453L (sv) 1985-03-25
GB8403257D0 (en) 1984-03-14

Similar Documents

Publication Publication Date Title
CN101812059B (zh) 一氧化氮供体型法尼基硫代水杨酸衍生物、其制备方法及其医药用途
CN113143965B (zh) 一种抑制肿瘤增殖的氨基富勒烯材料
SE437931B (sv) Lekemedelspreparat med antitumorverkan innehallande fosfat av polyhexametylenguanidin med angiven formel
CN111712245A (zh) 用于肝细胞癌的治疗剂
CN110464722B (zh) 一类小分子化合物或其药学上可接受的盐在制备抗肿瘤转移药物中的应用
RU2084449C1 (ru) 1-бензил-2-оксотриптамин гидрохлорид и его производные, обладающие гепатозащитной активностью
Fleysher et al. Some short-chain N6-substituted adenosine analogs with antitumor properties
US20230248717A1 (en) N-(3-hydroxypyridine-2-carbonyl)glycine-based antitumor drug sensitizer and application thereof
CN104326937B (zh) 抗肿瘤化合物及其医药用途
US7795434B2 (en) Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in manufacture of medicaments
CN108276354B (zh) Tlr4/md2抑制剂及其在抗炎药物中的应用
RU2506085C1 (ru) Тетраэтил-2-(2,2,6,6-тетраметилпиперидин-4-иламино)-этилен-1,1-бисфосфонат, обладающий противоопухолевой активностью
US20210132041A1 (en) Target for drug treatment of tumor metastasis and use thereof
CN111393368A (zh) 一种茚并吡唑盐酸盐类衍生物及其制备方法与应用
CN104892707A (zh) 一种定向合成化合物clcn及其在抗肝癌药物中的应用
CA1326487C (fr) Analogues de la mitomycine
Fisher et al. Stimulatory effect of amphotericin B methyl ester on the growth of LM and Vero cells
CN106995368A (zh) 一种非atp竞争性fgfr1抑制剂及其应用
SU1200851A3 (ru) Способ получени димера Винка или его фармацевтически приемлемых солей
US20170246138A1 (en) Method of treating or preventing tumors using 1-(alkylsulfinyl)-2-isothiocyanatoalkyl-1-alkene
CN114634551B (zh) 多肽及其在制备拮抗野生型p53与MDM2结合的抗癌药物中的应用
JPS59222417A (ja) N,N−ジエチル−5−メチル−2H−1−ベンゾチオピラノ−〔4,3,2−cd〕−インダゾ−ル−2−エタナミン組成物
JPH03184916A (ja) 抗腫瘍剤
US4939156A (en) New tetramethyl-cis-diaza-bicyclo{4.2.0}octane-3,5-dione derivatives having differentiation-inducing activity and antiviral activity
SE502110C2 (sv) Användning av en moranolinförening, nojirimycin eller castanospermin för framställning av en sammansättning med trombolytisk verkan.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8400453-0

Effective date: 19880318

Format of ref document f/p: F